Lomitapide Mesylate Patent Expiration
Lomitapide Mesylate is Used for treating hypercholesterolemia and hyperlipidemia in patients with homozygous familial hypercholesterolemia. It was first introduced by Chiesi Farmaceutici Spa
Lomitapide Mesylate Patents
Given below is the list of patents protecting Lomitapide Mesylate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Juxtapid | US7932268 | Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects | Aug 19, 2027 | Chiesi |
| Juxtapid | US10016404 | Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects |
Mar 07, 2025
(Expired) | Chiesi |
| Juxtapid | US10555938 | Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects |
Mar 07, 2025
(Expired) | Chiesi |
| Juxtapid | US8618135 | Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side effects |
Mar 07, 2025
(Expired) | Chiesi |
| Juxtapid | US9265758 | Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects |
Mar 07, 2025
(Expired) | Chiesi |
| Juxtapid | US9364470 | Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects |
Mar 07, 2025
(Expired) | Chiesi |
| Juxtapid | US9433617 | Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects |
Mar 07, 2025
(Expired) | Chiesi |
| Juxtapid | US9861622 | Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects |
Mar 07, 2025
(Expired) | Chiesi |
| Juxtapid | US5712279 | Inhibitors of microsomal triglyceride transfer protein and method |
Feb 21, 2020
(Expired) | Chiesi |
| Juxtapid | US6492365 | Microsomal triglyceride transfer protein |
Dec 10, 2019
(Expired) | Chiesi |
| Juxtapid | US5739135 | Inhibitors of microsomal triglyceride transfer protein and method |
Apr 14, 2015
(Expired) | Chiesi |
| Juxtapid | US5712279 | Inhibitors of microsomal triglyceride transfer protein and method |
Feb 21, 2015
(Expired) | Chiesi |
Lomitapide Mesylate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List